WARSAW, Poland, Nov. 13, 2024 (GLOBE NEWSWIRE) — Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, announced its second Center of Excellence (CoE) will open in Warsaw, Poland. The new CoE, alongside the one in India, strengthens Duck Creek’s
Building on an 8-Year Partnership, this Leading Service Provider Will Continue to Utilize Synchronoss Personal Cloud and Enable Subscribers throughout France to Manage, Optimize, and Share All Types of Digital Content BRIDGEWATER, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR), a global
11x San Francisco Team SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) — 11x, the leader in AI-powered digital workers for revenue teams, today announced the closing of a $50 million Series B funding round led by Andreessen Horowitz. The investment accelerates 11x’s digital workers further into the era of AI
SANTIAGO, Chile, Nov. 10, 2024 (GLOBE NEWSWIRE) — EBC Financial Group (EBC) is proud to announce the successful registration of its trademark in Chile, a milestone that strengthens EBC’s footprint in Latin America and reinforces its commitment to responsible market expansion and investor protection. This strategic move reflects EBC’s dedication
Bitget Protection Fund Hits $424 Million Average, a 40% Increase from its Initial Commitment VICTORIA, Seychelles, Nov. 08, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has released the latest valuation of its Protection Fund for October 2024. The fund, an essential safeguard for the exchange
Expands Lantronix’s IoT Wireless Connect Portfolio With Cutting-Edge 5G Technology Strengthens Competitive Offering, Adds New Blue-Chip Customers IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in IoT compute and connectivity IoT solutions, today announced that it has signed a definitive agreement to acquire
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the Company’s participation at the following healthcare investor conferences: Guggenheim’s Inaugural Healthcare
UTRECHT, The Netherlands, Nov. 07, 2024 (GLOBE NEWSWIRE) — Today, ATNi launches the 5th edition of the Global Access to Nutrition Index, the largest yet, assessing the world’s 30 largest food and beverage manufacturers and over 52,000 products, representing 23% global market share. One in five deaths globally is associated